Cited by 51Smoking Behavior and CessationSubstance Abuse Treatment and OutcomesTelemedicine and Telehealth Implementation

The DOI matches its Crossref record; 49 of the 49 references it cites were found in a registry or an index.

Feasibility and Preliminary Efficacy of a Web-Based Smoking Cessation Intervention for HIV-Infected Smokers: A Randomized Controlled Trial

Open access
Shuter, Jonathan, Morales, Daniela A., Considine-Dunn, Shannon E., An, Lawrence C., Stanton, Cassandra A.·2014·JAIDS Journal of Acquired Immune Deficiency Syndromes

Abstract

OBJECTIVE: To evaluate the feasibility and preliminary efficacy of a Web-based tobacco treatment for persons living with HIV (PLWH). DESIGN: Prospective, randomized controlled trial. SETTING: HIV-care center in the Bronx, New York. SUBJECTS: Eligibility criteria included HIV infection, current tobacco usage, interest in quitting, and access to a computer with internet. One hundred thirty-eight subjects enrolled, and 134 completed the study. INTERVENTION: Positively Smoke Free on the Web (PSFW), an 8-session, 7-week targeted tobacco treatment program for PLWH, was compared with standard care (brief advice to quit and self-help brochure). All subjects were offered nicotine patches. MAIN OUTCOME MEASURES: The main feasibility outcomes were number of sessions logged into, number of Web pages visited, number of interactive clicks, and total time logged in. The main efficacy outcome was biochemically verified, 7-day point prevalence abstinence 3 months after intervention. RESULTS: PSFW subjects logged into a mean of 5.5 of 8 sessions and 26.2 of 41 pages. They executed a mean of 10 interactive clicks during a mean total of 59.8 minutes logged in. Most required reminder phone calls to complete the sessions. Educational level, anxiety score, and home access of the Web site were associated with Web site usage. Ten percent of the PSFW group vs. 4.3% of controls achieved the abstinence end point. Among those who completed all 8 sessions, 17.9% were abstinent, and among women completers, 30.8% were abstinent. CONCLUSIONS: Web-based treatment is a feasible strategy for PLWH smokers, and preliminary findings suggest therapeutic efficacy.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1097/qai.0000000000000226

Cites

49 of 49 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Metadata

Authors
Shuter, J., Morales, D. A., Considine-Dunn, S. E., An, L. C., & Stanton, C. A.
Affiliations
  • Albert Einstein College of Medicine (US)
  • University of Michigan (US)
  • Georgetown University Medical Center (US)
Corresponding author
  • Shuter, Jonathan
  • Morales, Daniela A.
Venue
JAIDS Journal of Acquired Immune Deficiency Syndromes
Published
2014-09-01
Volume
67
Issue
1
Pages
59-66
ISSN
1525-4135 (ISSN-L)
OpenAlex
W2327613987
Cited by
51
References
49
Citations by year
2026: 1 · 2024: 5 · 2023: 5 · 2022: 3 · 2021: 4 · 2020: 2 · 2019: 4 · 2018: 4 · 2017: 4 · 2016: 13 · 2015: 4 · 2014: 2
FWCI
5.11
Type
journal article
Language
en
Open access
Locations
  • JAIDS Journal of Acquired Immune Deficiency Syndromes (publishedVersion)
  • PubMed (publishedVersion)
  • PubMed Central (acceptedVersion)
Funders
  • National Institutes of Health (UL1TR001073)
  • National Institute on Drug Abuse (R34DA037042)
  • National Cancer Institute (R21CA163100, P30CA051008, P30CA013330)
  • National Institute of Allergy and Infectious Diseases (AI-51519, P30AI051519)
  • National Center for Advancing Translational Sciences
Topics
  • Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Smoking Behavior and Cessation
  • Health Sciences › Medicine › Epidemiology › Substance Abuse Treatment and Outcomes
  • Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Telemedicine and Telehealth Implementation
Keywords
smoking cessation, HIV infection, online intervention, tobacco use, nicotine patch, abstinence, feasibility, internet use, women smokers, HIV care
MeSH terms
Breath Tests, Carbon Monoxide, Female, Humans, Male, New York City, Prospective Studies, Surveys and Questionnaires, HIV-1, HIV Infections, Logistic Models, Smoking Cessation, Internet

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review